BANK OF AMERICA CORP /DE/

Holdings History for Corvus Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (CRVS)

Symbol: CRVS on Nasdaq
Investment type: Equity / Common Stock, $0.0001 par value per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$1,821,011	236,495	+84,529	+56%	$7.70	Q4 2025
30 Sep 2025	0%	+0%	$1,119,989	151,966	+19,237	+14%	$7.37	Q3 2025
30 Jun 2025	0%	+0%	$530,916	132,729	+34,180	+35%	$4.00	Q2 2025
31 Mar 2025	0%	0%	$313,385	98,549	+1,568		$3.18	Q1 2025
31 Dec 2024	0%	+0%	$518,848	96,981	+96,572	+23612%	$5.35	Q4 2024
30 Sep 2024	0%	0%	$2,160	409	+17	+4.3%	$5.28	Q3 2024
30 Jun 2024	0%	0%	$713	392	+392	NEW	$1.82	Q2 2024
31 Mar 2024		0%	$0	0	-22	-100%	$19.74	Q1 2024
31 Dec 2023	0%	-0%	$39	22	-3,150	-99%	$1.77	Q4 2023
30 Sep 2023	0%	0%	$4,631	3,172	-1,907	-38%	$1.46	Q3 2023
30 Jun 2023	0%	+0%	$11,631	5,079	+5,079	NEW	$2.29	Q2 2023
31 Mar 2023		0%	$0	0	-70	-100%	$19.74	Q1 2023
31 Dec 2022	0%	0%	$60	70	+70	NEW	$0.86	Q4 2022
30 Jun 2022		0%	$0	0	-1,395	-100%	$19.74	Q2 2022
31 Mar 2022	0%	0%	$2,000	1,395	-933	-40%	$1.43	Q1 2022
31 Dec 2021	0%	+0%	$6,000	2,328	+2,328	NEW	$2.58	Q4 2021
30 Jun 2021		-0%	$0	0	-9,936	-100%	$19.74	Q2 2021
31 Mar 2021	0%	+0%	$31,000	9,936	+9,936	NEW	$3.12	Q1 2021
30 Jun 2020		-0%	$0	0	-3,619	-100%	$19.74	Q2 2020
31 Mar 2020	0%	-0%	$8,000	3,619	-19,192	-84%	$2.21	Q1 2020
31 Dec 2019	0%	-0%	$124,000	22,811	-24,616	-52%	$5.44	Q4 2019
30 Sep 2019	0%	-0%	$143,000	47,427	-30,817	-39%	$3.02	Q3 2019
30 Jun 2019	0%	+0%	$293,000	78,244	+6,715	+9.4%	$3.74	Q2 2019
31 Mar 2019	0%	-0%	$287,000	71,529	-8,699	-11%	$4.01	Q1 2019
31 Dec 2018	0%	+0%	$294,000	80,228	+19,399	+32%	$3.66	Q4 2018
30 Sep 2018	0%	+0%	$522,000	60,829	+6,820	+13%	$8.58	Q3 2018
30 Jun 2018	0%	+0%	$593,000	54,009	+1,358	+2.6%	$10.98	Q2 2018
31 Mar 2018	0%	+0%	$607,000	52,651	+44,969	+585%	$11.53	Q1 2018
31 Dec 2017	0%	+0%	$79,000	7,682	+7,291	+1865%	$10.28	Q4 2017
30 Sep 2017	0%	+0%	$6,000	391	+391	NEW	$15.35	Q3 2017
30 Jun 2017		-0%	$0	0	-2,782	-100%	$19.74	Q2 2017
31 Mar 2017	0%	0%	$58,000	2,782	-82	-2.9%	$20.85	Q1 2017
31 Dec 2016	0%	+0%	$41,000	2,864	+530	+23%	$14.32	Q4 2016
30 Sep 2016	0%	0%	$39,000	2,334	+75	+3.3%	$16.71	Q3 2016
30 Jun 2016	0%	+0%	$32,000	2,259	+2,259	NEW	$14.17	Q2 2016

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.